On Thursday, LifeVantage Corp (NASDAQ:LFVN)’s shares inclined 6.94% to $0.577.
LifeVantage Corp (LFVN) which takes an advanced, rounded approach to anti-aging and transformative health. The company makes and markets Protandim and Nrf2 Synergizer, two dietary supplements used to complement external sports-based health regiments created and studied by the company. By investigating all facets of health and wellness while supplementing exercise regiments with its skin care regiments an other health products, LifeVantage capitalizes on several untapped aspects of the personal care market.
The new wave of cosmetics and personal care companies like NUUU and LFVN stand poised to supplant some of the larger players incapable of adapting to advances in research, science, and marketing. With its celebrity associations and a fast track on the international market, NUUU in particular stands apart from the crowd, offering investors a company whose global interests make it primed for possible success.
While several key factors contribute to the success of any great brand, such as a quality product line, inventive advertising, and an practiced leadership team, few companies within this sector achieve widespread success without a growing presence in global markets. Rejuvel Bio-Sciences, Inc. (OTCQB: NUUU), which trades at .59 per share , has recently taken several steps to shore up its global brand appeal, strengthening the foundation of an up-and-coming brand ready to break through as a household name.
LifeVantage Corporation identifies, researches, develops, and distributes nutraceutical dietary supplements and skin care products. It offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; and Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. The company also provides skin care products, counting ultra gentle facial cleanser, perfecting lotion, eye corrector serum, and other versions of anti-aging cream products under the LifeVantage TrueScience brand name.
Novatel Wireless Inc (NASDAQ:MIFI)’s shares gained 0.58% to $3.46.
Novatel Wireless Inc (MIFI) reached a Transaction Implementation Agreement (the “Agreement”) with DigiCore Holdings Limited, a company incorporated under the company laws of the Republic of South Africa (“DigiCore”). The Agreement, which is binding upon the Company and DigiCore, constitutes (a) the Company’s notice to DigiCore of the Company’s firm intention to make an offer to acquire 100% of the issued and outstanding ordinary shares of DigiCore (with the exception of certain excluded shares, counting treasury shares), and (b) each party’s agreement to use all reasonable efforts to satisfy the conditions to the closing of the transaction. Irrevocable undertakings have been signed by holders of about 58% of DigiCore’s outstanding ordinary shares to vote in favor of the transaction. The acquisition will be implemented in accordance with the laws of South Africa and certain aspects of the transaction will be subject to the approval of the Takeover Regulation Panel in South Africa (the “TRP”). Upon consummation of the acquisition, Digicore will become an indirect wholly-owned partner of the Company.
As consideration for the acquisition, the Company will pay 4.40 South African Rand per share for a total cash purchase price of about USD $87 million, based on currency exchange rates in effect at the time that the Agreement was executed. As required under the laws of South Africa, the total cash purchase price has been guaranteed by a registered South African bank, based on the Company placing the full purchase consideration in escrow with the South African bank. DigiCore is required to prepare and circulate to the shareholders of DigiCore documents setting out the full terms and conditions of the Company’s offer (the “Offer”). There are certain conditions to the circulation of such documents, which comprise but are not limited to, waiver by counterparties to certain material contracts (counting certain employment agreements) of rights or benefits arising out of the projected change of control, approval of the transaction-related documents by the TRP, the Johannesburg Stock Exchange and other relevant governmental entities in South Africa, receipt of an independent expert’s opinion to the effect that the consideration being offered is “fair and reasonable,” and a unanimous recommendation by the independent board of directors of DigiCore that the shareholders of DigiCore vote in favor of the Offer.
Novatel Wireless, Inc. provides wireless broadband access solutions for the mobile communications market worldwide. It operates in the Mobile Computing Products, and M2M Products and Solutions segments. The Mobile Computing Products segment offers MiFi Intelligent Mobile Hotspots, the company’s flagship product providing connectivity option for Wi-Fi-enabled devices, such as iPad, Kindle, tablets, PCs, MP3 players, and gaming devices; 4G LTE Broadband Router with Voice, a wireless solution that supports wireless voice and data; USB and PC-Card/Expresscard modems for wireless broadband networks access; and embedded modules for use in computing devices, such as laptop PCs, netbooks, tablets, and other electronic products to provide wireless broadband access.
At the end of Thursday’s trade, Maxim Integrated Products Inc. (NASDAQ:MXIM)‘s shares dipped -0.01% to $35.33.
Maxim Integrated Products Inc. (MXIM) stated net revenue of $577 million for its third quarter of fiscal 2015 ended March 28, 2015, a 2% enhance from the $567 million revenue recorded in the preceding quarter, and a 5% decrease from the same quarter of last year.
Fiscal Year 2015 Third Quarter Results
Based on Generally Accepted Accounting Principles (GAAP), diluted earnings per share in the March quarter was $0.28. The results were affected by pre-tax special items which primarily comprised of $23 million in charges related to acquisitions and $17 million in charges related to restructuring activities. GAAP earnings per share, not taking into account special items was $0.40. An analysis of GAAP as compared to GAAP not taking into account special items is offered in the last table of this press release.
Maxim Integrated Products, Inc. designs, develops, manufactures, and markets various linear and mixed-signal integrated circuits worldwide. The company also provides a range of high-frequency process technologies and capabilities for use in custom designs. It primarily serves automotive, communications and data center, computing, consumer, and industrial markets.
PDL BioPharma Inc (NASDAQ:PDLI), ended its Thursday’s trading session with -0.46% loss, and closed at $6.50.
PDL BioPharma Inc (PDLI) declared that John P. McLaughlin, the company’s president and chief executive officer, will present at the Nasdaq 32nd Investor Program in London, England. The fireside chat-style of presentation will be webcast and will occur on Tuesday, June 30, 2015 at 8:30 a.m. BST / 3:30 a.m. EDT.
PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. PDL BioPharma, Inc. has license agreements with various biotechnology and pharmaceutical companies, in addition to acquires royalty and other assets.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
